1 |
100 µg brimonidine tartrate implant |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
2 |
200 µg brimonidine tartrate implant |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
3 |
400 µg brimonidine tartrate implant |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
4 |
4d-125 ivt injection |
- |
- |
- |
- |
090 [1] 90 💬 |
5 |
9715x |
- |
- |
- |
- |
090 [1] 90 💬 |
6 |
9741x |
- |
- |
- |
- |
090 [1] 90 💬 |
7 |
9742x |
- |
- |
- |
- |
090 [1] 90 💬 |
8 |
Aav-rpgr |
- |
- |
- |
- |
090 [1] 90 💬 |
9 |
Aav2-rep1 |
- |
- |
- |
- |
090 [1] 90 💬 |
10 |
Aav2/5-hpde6b |
- |
- |
- |
- |
090 [1] 90 💬 |
11 |
Aav2/5-hrkp.rpgr |
- |
- |
- |
- |
090 [1] 90 💬 |
12 |
Aav8-rpgr |
- |
- |
- |
- |
090 [1] 90 💬 |
13 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
14 |
Acetazolamide |
Acetazolamide |
[2] D00218 D00218, D01196 D01196 💬 |
CA1 [13] CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 |
Bile secretion [7] Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation |
013 [6] 13, 90, 115, 155, 225, 230 💬 |
15 |
Aflibercept |
Aflibercept |
[1] D09574 D09574 💬 |
PGF [3] PGF, VEGFA, VEGFB 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway |
090 [2] 90, 166 💬 |
16 |
Alga dunaliella bardawil |
- |
- |
- |
- |
090 [1] 90 💬 |
17 |
Alga dunaliella bardawil powder |
- |
- |
- |
- |
090 [1] 90 💬 |
18 |
Alga dunaliella bardawill |
- |
- |
- |
- |
090 [1] 90 💬 |
19 |
Allogeneic neural retina-derived human neural retinal progenitor cells ex vivo expanded |
- |
- |
- |
- |
090 [1] 90 💬 |
20 |
Antioxidants |
- |
- |
- |
- |
090 [3] 90, 298, 310 💬 |
21 |
Betamethasone |
Betamethasone |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [6] 2 , 28, 46, 90, 96, 235 💬 |
22 |
Bmmncs |
- |
- |
- |
- |
090 [1] 90 💬 |
23 |
Brimonidine |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 [2] 13, 90 💬 |
24 |
Brimonidine tartrate |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 [2] 13, 90 💬 |
25 |
Brimonidine tartrate posterior segment drug delivery system (brimo ps dds) applicator system |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
26 |
Bs01 |
- |
- |
- |
- |
090 [1] 90 💬 |
27 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 [8] 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
28 |
Carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 [9] 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
29 |
Cd34+ bone marrow stem cells intravitreal |
- |
- |
- |
- |
090 [1] 90 💬 |
30 |
Cholesterol |
Cholesterol |
[1] D00040 D00040 💬 |
- |
- |
019 [6] 19, 90, 160, 259, 261, 310 💬 |
31 |
Ciliary neurotrophic factor |
Ciliary neurotrophic factor |
- |
- |
- |
090 [1] 90 💬 |
32 |
Ciliary neurotrophic factor implant nt-501 |
Ciliary neurotrophic factor |
- |
- |
- |
090 [1] 90 💬 |
33 |
Circadin |
- |
- |
- |
- |
006 [3] 6 , 13, 90 💬 |
34 |
Circadin 2 mg |
- |
- |
- |
- |
090 [1] 90 💬 |
35 |
Circadin 2 mg comprimidos de liberación prolongada |
- |
- |
- |
- |
090 [1] 90 💬 |
36 |
Cns10-npc implantation |
- |
- |
- |
- |
090 [1] 90 💬 |
37 |
Cnto 2476 |
- |
- |
- |
- |
090 [1] 90 💬 |
38 |
Combination product: prp combined magnovision |
- |
- |
- |
- |
090 [1] 90 💬 |
39 |
Compound thrombosis capsule sig: 1.5g/tid |
- |
- |
- |
- |
090 [1] 90 💬 |
40 |
Conditioned medium (cm) |
- |
- |
- |
- |
090 [1] 90 💬 |
41 |
Continuous oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
090 [1] 90 💬 |
42 |
Coqun |
- |
- |
- |
- |
090 [1] 90 💬 |
43 |
Cornstarch |
Starch, corn |
[1] D05297 D05297 💬 |
- |
- |
090 [2] 90, 257 💬 |
44 |
Cornstarch control |
Starch, corn |
[1] D05297 D05297 💬 |
- |
- |
090 [1] 90 💬 |
45 |
Cpk850 |
- |
- |
- |
- |
090 [1] 90 💬 |
46 |
Cyclosporine |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 [35] 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
47 |
Cysteine |
Cysteine |
[2] D00026 D00026, D02326 D02326 💬 |
- |
- |
006 [11] 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
48 |
Dac |
- |
- |
- |
- |
013 [3] 13, 90, 301 💬 |
49 |
Dds |
- |
- |
- |
- |
090 [1] 90 💬 |
50 |
Device: blue light-absorbing sunglasses |
- |
- |
- |
- |
090 [1] 90 💬 |
51 |
Device: dexamethasone injection |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
090 [1] 90 💬 |
52 |
Device: medmont darl adapted chromatic (dac) |
- |
- |
- |
- |
090 [2] 90, 301 💬 |
53 |
Device: moncvone electrophysiology |
- |
- |
- |
- |
090 [2] 90, 301 💬 |
54 |
Device: retmap, rm electrode |
- |
- |
- |
- |
090 [2] 90, 301 💬 |
55 |
Dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
56 |
Diagnostic test: ocular coherence tomography-angiography (oct-a) |
- |
- |
- |
- |
090 [2] 90, 301 💬 |
57 |
Docosahexaenoic acid |
Doconexent |
- |
- |
- |
006 [7] 6 , 49, 90, 94, 240, 299, 301 💬 |
58 |
Dorzolamide |
Dorzolamide |
[2] D00653 D00653, D07871 D07871 💬 |
CA1 [13] CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 |
Bile secretion [7] Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation |
090 [1] 90 💬 |
59 |
Eylea |
- |
- |
- |
- |
090 [2] 90, 166 💬 |
60 |
Fluocinolone |
Fluocinolone |
- |
- |
- |
090 [1] 90 💬 |
61 |
Fluocinolone acetonide |
Fluocinolone |
[1] D01825 D01825 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
090 [1] 90 💬 |
62 |
Ginkgo |
Ginkgo biloba |
- |
- |
- |
006 [4] 6 , 13, 18, 90 💬 |
63 |
Ginkgo biloba |
Ginkgo biloba |
- |
- |
- |
013 [3] 13, 18, 90 💬 |
64 |
Ginkgo biloba pills sig: 300mg/tid |
Ginkgo biloba |
- |
- |
- |
090 [1] 90 💬 |
65 |
Gs030-dp |
- |
- |
- |
- |
090 [1] 90 💬 |
66 |
Hora-pde6b (aav2/5.hpde6b) |
- |
- |
- |
- |
090 [1] 90 💬 |
67 |
Hrpc |
- |
- |
- |
- |
090 [1] 90 💬 |
68 |
Hrpc dp |
- |
- |
- |
- |
090 [1] 90 💬 |
69 |
Human embryonic stem cell derived retinal pigment epithelium (rpe) |
- |
- |
- |
- |
090 [1] 90 💬 |
70 |
Human primary retinal pigment epithelial (hurpe) cells |
- |
- |
- |
- |
090 [1] 90 💬 |
71 |
Human retinal progenitor cells |
- |
- |
- |
- |
090 [1] 90 💬 |
72 |
Human retinal progenitor cells drug product |
- |
- |
- |
- |
090 [1] 90 💬 |
73 |
Hydroxychloroquine |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
013 [23] 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
74 |
Hydroxychloroquine higher dose |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
090 [1] 90 💬 |
75 |
Hydroxychloroquine lower dose |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
090 [1] 90 💬 |
76 |
Iluvien |
- |
- |
- |
- |
090 [1] 90 💬 |
77 |
Intravitreal injection of autologous bone marrow stem cell |
- |
- |
- |
- |
090 [1] 90 💬 |
78 |
Intravitreal injection of autologous bone marrow stem cells |
- |
- |
- |
- |
090 [1] 90 💬 |
79 |
Lentiviral vector containing myo7a gene |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
80 |
Lentiviral vector containing the human my07a gene |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
81 |
Levodopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [8] 2 , 4 , 6 , 17, 90, 140, 164, 201 💬 |
82 |
Levodopa-carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [2] 6 , 90 💬 |
83 |
Lutein |
Lutein |
- |
- |
- |
090 [2] 90, 164 💬 |
84 |
Lutein (10 or 30 mg/day) capsules |
Lutein |
- |
- |
- |
090 [1] 90 💬 |
85 |
Lycium barbarum |
- |
- |
- |
- |
090 [1] 90 💬 |
86 |
Melatonin |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
006 [11] 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
87 |
Minocycline |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
002 [13] 2 , 6 , 8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
88 |
N-acetyl cysteine (nac) |
Cysteine |
[2] D00026 D00026, D02326 D02326 💬 |
- |
- |
090 [1] 90 💬 |
89 |
Nac |
- |
- |
- |
- |
034 [5] 34, 51, 85, 90, 299 💬 |
90 |
Nac effervescent tablets |
- |
- |
- |
- |
090 [1] 90 💬 |
91 |
Nerve growt factor - 2.5s |
- |
- |
- |
- |
090 [1] 90 💬 |
92 |
Nerve growth factor |
Nerve Growth Factor |
- |
- |
- |
003 [2] 3 , 90 💬 |
93 |
Nilvadipine |
Nilvadipine |
[1] D01908 D01908 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
94 |
Npi-001 |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
95 |
Nt-501 |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
96 |
Null |
- |
- |
- |
- |
006 [16] 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
97 |
Nutritional supplement |
- |
- |
- |
- |
090 [1] 90 💬 |
98 |
Other: mock injection |
- |
- |
- |
- |
090 [1] 90 💬 |
99 |
Other: observational |
- |
- |
- |
- |
090 [1] 90 💬 |
100 |
Other: sham (no implant) |
- |
- |
- |
- |
090 [1] 90 💬 |
101 |
Other: sham procedure |
- |
- |
- |
- |
090 [1] 90 💬 |
102 |
Other: sham-procedure (dose cohort 1&2 only) |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
103 |
Other: standard of care sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
090 [2] 90, 301 💬 |
104 |
Other: subconjunctival injection of saline |
- |
- |
- |
- |
090 [1] 90 💬 |
105 |
Other: sugar pill |
- |
- |
- |
- |
090 [1] 90 💬 |
106 |
Other: visual acuity (va) |
- |
- |
- |
- |
090 [2] 90, 301 💬 |
107 |
Oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
108 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 [30] 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
109 |
Platelet rich plasma |
- |
- |
- |
- |
046 [2] 46, 90 💬 |
110 |
Procedure: hyperbaric oxygen therapy |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
090 [1] 90 💬 |
111 |
Procedure: sham |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
112 |
Prp |
- |
- |
- |
- |
090 [1] 90 💬 |
113 |
Ps |
- |
- |
- |
- |
046 [3] 46, 90, 97 💬 |
114 |
Qlt091001 |
- |
- |
- |
- |
090 [1] 90 💬 |
115 |
Qr-1123 |
- |
- |
- |
- |
090 [1] 90 💬 |
116 |
Qr-421a |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
117 |
Raav.hpde6a vector |
- |
- |
- |
- |
090 [1] 90 💬 |
118 |
Raav2tyf-grk1-rpgr |
- |
- |
- |
- |
090 [1] 90 💬 |
119 |
Recombinant adeno-associated viral vector serotype 2.7m8 containing the chrimsonr-tdtomato gene |
- |
- |
- |
- |
090 [1] 90 💬 |
120 |
Recombinant human nerve growth factor (rhngf) |
Cenegermin |
[1] D11028 D11028 💬 |
NGFR [1] NGFR 💬 |
Apoptosis - multiple species [8] Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer |
090 [1] 90 💬 |
121 |
Retinal pigment epitheliums transplantation |
- |
- |
- |
- |
090 [1] 90 💬 |
122 |
Rhngf |
Cenegermin |
[1] D11028 D11028 💬 |
NGFR [1] NGFR 💬 |
Apoptosis - multiple species [8] Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer |
090 [1] 90 💬 |
123 |
Rhngf 180 µg/ml eye drops solution |
Cenegermin |
[1] D11028 D11028 💬 |
NGFR [1] NGFR 💬 |
Apoptosis - multiple species [8] Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer |
090 [1] 90 💬 |
124 |
Rhngf 60 µg/ml eye drops solution |
Cenegermin |
[1] D11028 D11028 💬 |
NGFR [1] NGFR 💬 |
Apoptosis - multiple species [8] Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer |
090 [1] 90 💬 |
125 |
Rst-001 |
- |
- |
- |
- |
090 [1] 90 💬 |
126 |
Sar421869 |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
127 |
Sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
128 |
Sodium valproate |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 [4] 2 , 90, 102, 256 💬 |
129 |
Stem cell transplantation |
- |
- |
- |
- |
013 [10] 13, 19, 20, 46, 65, 90, 125, 164, 234, 326 💬 |
130 |
Stem/progenitor cells transplantation |
- |
- |
- |
- |
090 [2] 90, 301 💬 |
131 |
Subretinal injection of raav.hpde6a |
- |
- |
- |
- |
090 [1] 90 💬 |
132 |
Subretinal injection of umbilical cord blood platelet-rich plasma (cb-prp) |
- |
- |
- |
- |
090 [1] 90 💬 |
133 |
Timrepigene emparvovec |
Timrepigene emparvovec |
- |
- |
- |
090 [1] 90 💬 |
134 |
Tocoferol |
Tocopherol |
[1] D02332 D02332 💬 |
- |
- |
090 [1] 90 💬 |
135 |
Triamcinolone |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [8] 35, 46, 56, 70, 90, 96, 226, 298 💬 |
136 |
Twice-daily dosage with 0.5% cyclosporine-a eyedrops |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
137 |
Uf-021 |
- |
- |
- |
- |
090 [1] 90 💬 |
138 |
Uf-021 (isopropyl unoprostone) |
Unoprostone |
[1] D08661 D08661 💬 |
PTGFR [1] PTGFR 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway |
090 [1] 90 💬 |
139 |
Uf-021(isopropyl unoprostone) |
Unoprostone |
[1] D08661 D08661 💬 |
PTGFR [1] PTGFR 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway |
090 [1] 90 💬 |
140 |
Umbilical cord mesenchymal stem cell (uc-msc) |
- |
- |
- |
- |
090 [1] 90 💬 |
141 |
Unoprostone |
Unoprostone |
[1] D08661 D08661 💬 |
PTGFR [1] PTGFR 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway |
090 [1] 90 💬 |
142 |
Ushstat |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
143 |
Ushstat (sar421869) |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
144 |
Va |
- |
- |
- |
- |
090 [3] 90, 301, 302 💬 |
145 |
Valproate |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 [6] 2 , 3 , 90, 102, 233, 256 💬 |
146 |
Valproic acid |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [10] 3 , 5 , 26, 34, 65, 89, 90, 222, 256, 331 💬 |
147 |
Vehicle eye drops |
- |
- |
- |
- |
090 [1] 90 💬 |
148 |
Vitamin a |
Vitamin A |
[2] D00069 D00069, D06543 D06543 💬 |
RARA [2] RARA, RARB 💬 |
Acute myeloid leukemia [8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
013 [3] 13, 53, 90 💬 |
149 |
Vitamin ad sig: 1 tablet/tid |
- |
- |
- |
- |
090 [1] 90 💬 |
150 |
Vitamin b sig: 10mg/tid |
- |
- |
- |
- |
090 [1] 90 💬 |
151 |
Vitamin e |
Vitamin E |
[1] D02331 D02331 💬 |
- |
- |
002 [11] 2 , 6 , 13, 20, 46, 90, 96, 97, 206, 299, 317 💬 |
152 |
Wharton's jelly derived mesenchymal stem cell |
- |
- |
- |
- |
090 [1] 90 💬 |
153 |
Zuretinol acetate |
Acetate |
- |
- |
- |
090 [1] 90 💬 |